Jnba Financial Advisors Bristol Myers Squibb CO Transaction History

Jnba Financial Advisors

$947 Million
Q2 2024

A detailed history of Jnba Financial Advisors transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Jnba Financial Advisors holds 5,900 shares of BMY stock, worth $313,821. This represents 0.03% of its overall portfolio holdings.

Number of Shares

5,900

Previous 5,650 4.42%

Holding current value

$313,821

Previous $306,000 19.93%

% of portfolio

0.03%

Previous 0.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	BUY	$40.25 - $52.99 $10,062 - $13,247	250 Added 4.42%	5,900 $245,000
Q1 2024 Apr 26, 2024	SELL	$47.98 - $54.4 $143 - $163	-3 Reduced 0.05%	5,650 $306,000
Q4 2023 Feb 07, 2024	SELL	$48.48 - $57.85 $45,765 - $54,610	-944 Reduced 14.31%	5,653 $290,000
Q3 2023 Nov 02, 2023	BUY	$57.89 - $64.73 $27,324 - $30,552	472 Added 7.71%	6,597 $382,000
Q2 2023 Aug 03, 2023	SELL	$63.71 - $70.74 $53,834 - $59,775	-845 Reduced 12.12%	6,125 $391,000
Q1 2023 May 01, 2023	BUY	$65.71 - $74.53 $58,481 - $66,331	890 Added 14.64%	6,970 $483,000
Q4 2022 Feb 06, 2023	SELL	$68.48 - $81.09 $20,544 - $24,327	-300 Reduced 4.7%	6,080 $437,000
Q3 2022 Nov 07, 2022	SELL	$0.13 - $76.84 $74 - $43,875	-571 Reduced 8.21%	6,380 $454,000
Q2 2022 Jul 22, 2022	SELL	$72.62 - $79.98 $14,160 - $15,596	-195 Reduced 2.73%	6,951 $535,000
Q4 2021 Feb 03, 2022	BUY	$53.63 - $62.52 $166,521 - $194,124	3,105 Added 76.84%	7,146 $446,000
Q1 2021 May 03, 2021	BUY	$59.34 - $66.74 $5,637 - $6,340	95 Added 2.41%	4,041 $255,000
Q4 2020 Jan 25, 2021	BUY	$57.74 - $65.43 $4,330 - $4,907	75 Added 1.94%	3,946 $245,000
Q3 2020 Nov 05, 2020	SELL	$57.43 - $63.64 $34,458 - $38,184	-600 Reduced 13.42%	3,871 $233,000
Q2 2020 Jul 24, 2020	SELL	$54.82 - $64.09 $109 - $128	-2 Reduced 0.04%	4,471 $263,000
Q4 2019 Feb 10, 2020	BUY	$49.21 - $64.19 $19,241 - $25,098	391 Added 9.58%	4,473 $287,000
Q3 2019 Nov 01, 2019	BUY	$42.77 - $50.71 $64,155 - $76,065	1,500 Added 58.09%	4,082 $207,000
Q2 2019 Jul 26, 2019	BUY	$44.62 - $49.34 $4,462 - $4,934	100 Added 4.03%	2,582 $117,000
Q4 2018 Feb 07, 2019	SELL	$48.76 - $63.23 $514,076 - $666,633	-10,543 Reduced 80.94%	2,482 $129,000
Q3 2018 Nov 01, 2018	BUY	$55.19 - $62.25 $558,688 - $630,156	10,123 Added 348.83%	13,025 $809,000
Q1 2018 May 07, 2018	BUY	$59.92 - $68.98 $36,071 - $41,525	602 Added 26.17%	2,902 $2.9 Million
Q4 2017 Jan 31, 2018	SELL	$59.94 - $65.35 $26,073 - $28,427	-435 Reduced 15.9%	2,300 $141,000
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $2,761 - $3,187	50 Added 1.86%	2,735 $174,000
Q2 2017 Aug 14, 2017	BUY	N/A	2,685	2,685 $150,000

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jnba Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Jnba Financial Advisors with notifications on news.

Account

Jnba Financial Advisors Bristol Myers Squibb CO Transaction History